FDA Fast-Tracks Psychedelic Treatments for Depression, PTSD

The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions.

Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.